SHS Capital and ING Corporate Investments Acquire Majority Stake in CAM Bioceramics
July 7, 2023
German healthcare specialist investor SHS Capital, together with ING Corporate Investments and several co-investors, acquired a majority stake in CAM Bioceramics B.V., a Leiden-based contract development and manufacturing organization (CDMO) for orthobiologic calcium phosphate solutions. Existing owners rolled over a significant stake and management remains in place; the transaction aims to strengthen the business and accelerate investment in people, capabilities and customer partnerships to drive growth.
- Buyers
- SHS Capital, ING Corporate Investments, Several Co-Investors
- Targets
- CAM Bioceramics B.V.
- Sellers
- Existing shareholders (rolled over significant stake)
- Industry
- Medical Devices
- Location
- South Holland, Netherlands
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.